Yilong Wang
Clinical trials sponsored by Yilong Wang, explained in plain language.
-
Skull injection breakthrough tested for deadly brain infections
Disease control Not yet recruitingThis study tests whether injecting antibiotics directly into the skull bone marrow, combined with standard IV antibiotics, works better than IV antibiotics alone for severe bacterial meningitis. It's for patients aged 18-75 whose severe brain infection isn't improving after 2-3 d…
Phase: NA • Sponsor: yilong Wang • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New protein therapy tested for rare brain disease
Disease control Not yet recruitingThis study is testing a new protein therapy called ALT001 in people with multiple system atrophy (MSA), a rare and serious brain disorder. The main goal is to check if the treatment is safe and well-tolerated, while also looking for early signs that it might help slow the disease…
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC